The Future of CBD Recently, the company GW pharmaceuticals and the CBD-based drug it manufactures, Epidiolex, made headlines around the world. Epidiolex shows promising results as an effective epilepsy medication for young sufferers of various rare forms of the disorder; even those deemed “medically intractable”. At the American Epilepsy Society Annual Meeting in Philadelphia, GW produced the results